Navigation Links
Relief For British MS Patients: Cannabis-Based Oral Spray

Multiple sclerosis patients in Britain can look forward to some relief, as a cannabis-based medicine is being made available to them for the first time, following approval from the Home Office for its importation from Canada. //

Patients in Britain will soon be able to obtain an unlicensed, cannabis-based medicine on prescription to treat multiple sclerosis and possibly rheumatoid arthritis even though it is yet to be licensed in the UK. The Home Office has allowed the mouth spray drug to be imported for individual patients in exceptional cases, provided their clinician believes they will benefit.

The Home Office has agreed to requests from doctors and patients to allow Sativex to be imported from Canada, where it has been on sale since late June. The oral spray derived from the cannabis plant will be available on prescription for around £4 a day. Research indicates that it relieves the pain and spasticity associated with multiple sclerosis.

The drug, Sativex, is made by GW Pharmaceuticals from a combination of plant extracts using nearly equal measures of tetrahydrocannibol (THC) and cannabidiol, also present in cannabis. The Home Office sanctioned imports from Canada.

GW Pharmaceuticals is seeking a licence in Britain to use the drug to treat spasticity - painful stiffness linked to MS - but regulators want more proof that it works.

Mike O'Donovan, chief executive of the Multiple Sclerosis Society, said: "Many people ... will now have the opportunity to try a new drug which could significantly improve their quality of life. We very much hope it will not be long before it is licensed for NHS prescription."

A Department of Health spokesman said: "It is vital that we ensure that drugs are safe before they are used in the NHS. It is for this reason that Jane Kennedy, the health minister, has referred Sativex to the Commission on Human Medicines to determine its safety, quality and efficacy."

Related medicine news :

1. Pancreatitis: Minimially Invasive Procedure Offers Long-Term Pain Relief
2. Relief from common back pain
3. Relief to pregnant women using fertility drugs
4. Relief of pain for suffering patients
5. Relief from cancer pain with anticonvulsants
6. Relief from Migraine
7. Pain Relief For Osteoarthritis Patients
8. Relief From Migraines
9. Effective Pain Relief For Patients Suffering From Multiple Sclerosis
10. Drug Found To Bring Relief For Individuals With Early Parkinson’
11. Relief For Women Suffering From Fibromyalgia
Post Your Comments:

(Date:11/25/2015)... ... November 25, 2015 , ... Bcureful—a non-profit organization devoted to ... raising public awareness of the disorder while helping to bring expert medical care ... to bolster progress at the Tuberous Sclerosis Complex Center at Ann & Robert ...
(Date:11/24/2015)... , ... November 24, 2015 , ... ... to offer their patients the many benefits of the revolutionary BIOLASE WaterLase iPlus ... cutting and scraping tools traditionally used by a dentist in Gettysburg, PA ...
(Date:11/24/2015)... ... 24, 2015 , ... ThirdLove, the fast-growing bra company that ... offering 40% off select bras and underwear styles, now through Saturday, November 28th. ... technology and the latest fashion, quickly becoming the next generation of luxury bras. ...
(Date:11/24/2015)... ... 24, 2015 , ... Preparing for the LDT Regulation:, CLIA Won’t Satisfy the ... , FDA has long asserted that design and manufacture of Laboratory Developed Tests ... do not meet the device regulations. , Come up short in an inspection and ...
(Date:11/24/2015)... ... November 24, 2015 , ... United Benefit Advisors (UBA), ... & Company as its newest Partner Firm. Based in Jefferson City, Missouri, their ... trusted advisor regardless of whether that client is a business, a family, or ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , November 25, 2015 ... Investors"), pursuant to which BioLight and the New Investors ... Ltd. subsidiary ("IOPtima") via a private placement. The financing ... its innovative IOPtimate™ system used in the treatment of ... pathway process for the IOPtimate™ system with the U.S. ...
(Date:11/25/2015)... 2015 Developmental, commercial, and regulatory/legal ... profitability of pharmaceutical products, says GBI Research ... regulatory/legal strategies all play a key role in boosting ... . --> Developmental, commercial, ... in boosting the profitability of pharmaceutical products, says ...
(Date:11/25/2015)... Research and Markets ( ) has ... Global Forecast to 2020" report to their offering. ... 37.21% of the total market share in 2014. The ... is projected to growth at the highest CAGR between ... to the fast growing water, industrial gas treatment, pharmaceutical, ...
Breaking Medicine Technology: